What is the share price of DIVISLAB today?
The share price of Divi's Laboratories Limited (traded on the National Stock Exchange of India under the ticker DIVISLAB) is approximately 8,585.00 INR. Divi's Laboratories is a prominent Indian pharmaceutical company specializing in the manufacture of active pharmaceutical ingredients, custom synthesis of advanced intermediates, and nutraceutical ingredients for global markets. Its stock performance responds directly to international export demands, regulatory compliance audits by global health authorities, research and development capabilities, cost efficiencies, and overarching trends in the global healthcare sector.
Related FAQs
Nilima Prasad Divi, a prominent corporate leader and key promoter associated with the successful pharmaceutical powerhouse Divi's Laboratories, commands a substantial personal net worth running into millions of dollars (spanning billions of Indian ru...
Divi's Laboratories Limited is a prominent Indian pharmaceutical enterprise specializing in the manufacture of high-quality active pharmaceutical ingredients, custom synthesis intermediates, and nutraceutical ingredients.
Divi's Laboratories is generally considered a high-quality company, recognized as a leading global manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates.
As of late July 2026, some financial analysis models indicate that Divi's Laboratories is currently "overvalued" based on estimates of its intrinsic value.
Divi's Laboratories Limited trades with a trailing price-to-earnings ratio hovering around 73.1 to 78.3, reflecting its elite positioning as a premier global manufacturer of active pharmaceutical ingredients and custom synthesis products.
Divi's Laboratories is widely characterized as being "almost debt free" according to recent financial analysis.
Divi's Laboratories Limited (DIVISLAB) is widely regarded as a premier active pharmaceutical ingredient (API) and custom synthesis manufacturing powerhouse in India, boasting world-class production facilities, exceptional quality compliance records, ...
It is important to clarify that "Divi" can refer to multiple entities, and there is no singular individual or business with a widely recognized public "net worth" by that specific name.
Institutional brokerages covering Divi's Laboratories Limited maintain consensus price targets clustering around an average of approximately Rs 4,250, with bull-case estimates stretching higher based on active pharmaceutical ingredient demand cycles.
Divi's Laboratories future price evaluations by market analysts focus on its strong global positioning in active pharmaceutical ingredients, custom synthesis, and intermediate drug manufacturing.
Dr. Murali K. Divi, serving as the Chairman and Managing Director of Divi's Laboratories, has historically been recognized as one of the highest-paid executive leaders in the Indian pharmaceutical sector.
Divi's Laboratories, often referred to as DIVISLAB, is a global leader in the pharmaceutical industry, specifically known for the manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates, and nutraceuticals.
Divi's Laboratories is frequently discussed as a candidate for long-term portfolios due to its specialized business model, strong balance sheet, and consistent historical performance.
Yes, Divi's Laboratories Limited is an Indian multinational pharmaceutical company. It is headquartered in Hyderabad, Telangana, where it manages its primary research and development and manufacturing operations.